Finch Therapeutics, Inc. — Form D
Finch Therapeutics, Inc. of Somerville, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-23. The offering totals $3.8M, of which $3.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-01-23
- Form: D
- Accession: 0001140361-17-002513
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.8M
- Amount sold: $3.7M
- Remaining: $16K
- Investors: 6
- Date of first sale: 2016-12-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278987
Issuer
- Name: Finch Therapeutics, Inc.
- CIK: 0001661704
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 200 Inner Belt Road, Somerville, MA, 02143
- Phone: 617-229-6499
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| James Burgess | Director | Provo, UT |
| Andrew Noh | Director | Somerville, MA |
| Mark Smith | Director | Palo Alto, CA |
| Andrew Noh | Executive Officer | Somerville, MA |
| Mark Smith | Executive Officer | Palo Alto, CA |
| Eric Alm | Promoter | Somerville, MA |
| James Burgess | Promoter | Provo, UT |
| Zain Kassam | Promoter | Somerville, MA |
| Andrew Noh | Promoter | Somerville, MA |
| Mark Smith | Promoter | Palo Alto, CA |
| William Perkins | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More